These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23952137)

  • 1. Lipid-lowing pharmacogenomics in Chinese patients.
    Hu M; Tomlinson B
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):985-97. PubMed ID: 23952137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of lipid-lowering therapies.
    Hu M; Tomlinson B
    Pharmacogenomics; 2013 Jun; 14(8):981-95. PubMed ID: 23746191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics and adverse drug reactions: the case of statins.
    Giorgi MA; Caroli C; Arazi HC; Di Girolamo G
    Expert Opin Pharmacother; 2011 Jul; 12(10):1499-509. PubMed ID: 21568825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of statin response.
    Mangravite LM; Wilke RA; Zhang J; Krauss RM
    Curr Opin Mol Ther; 2008 Dec; 10(6):555-61. PubMed ID: 19051133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Pharmacogenetics on Efficacy and Safety of Statin Therapy for Dyslipidemia.
    Maxwell WD; Ramsey LB; Johnson SG; Moore KG; Shtutman M; Schoonover JH; Kawaguchi-Suzuki M
    Pharmacotherapy; 2017 Sep; 37(9):1172-1190. PubMed ID: 28672099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of pharmacogenomic VIP variants in the Kyrgyz population from northwest China.
    Yunus Z; Liu L; Wang H; Zhang L; Li X; Geng T; Kang L; Jin T; Chen C
    Gene; 2013 Oct; 529(1):88-93. PubMed ID: 23954225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of statins therapy.
    Puccetti L; Acampa M; Auteri A
    Recent Pat Cardiovasc Drug Discov; 2007 Nov; 2(3):228-36. PubMed ID: 18221122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of statins: achievements, whole-genome analyses and future perspectives.
    Postmus I; Verschuren JJ; de Craen AJ; Slagboom PE; Westendorp RG; Jukema JW; Trompet S
    Pharmacogenomics; 2012 May; 13(7):831-40. PubMed ID: 22594514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of pharmacogenetic variation on the effects of statins.
    Maggo SD; Kennedy MA; Clark DW
    Drug Saf; 2011 Jan; 34(1):1-19. PubMed ID: 21142270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics of cholesterol-lowering therapy.
    Schmitz G; Langmann T
    Vascul Pharmacol; 2006 Feb; 44(2):75-89. PubMed ID: 16337220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and myotoxicity: a therapeutic limitation.
    Tiwari A; Bansal V; Chugh A; Mookhtiar K
    Expert Opin Drug Saf; 2006 Sep; 5(5):651-66. PubMed ID: 16907655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of VIP variants in the Tajik ethnic group of northwest China.
    Zhang J; Jin T; Yunus Z; Li X; Geng T; Wang H; Cui Y; Chen C
    BMC Genet; 2014 Sep; 15():102. PubMed ID: 25266489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia.
    Hu M; Tomlinson B
    Atherosclerosis; 2012 Aug; 223(2):427-32. PubMed ID: 22749334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin dose in Asians: is pharmacogenetics relevant?
    Wang P
    Pharmacogenomics; 2011 Nov; 12(11):1605-15. PubMed ID: 22044416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transporter pharmacogenetics and statin toxicity.
    Niemi M
    Clin Pharmacol Ther; 2010 Jan; 87(1):130-3. PubMed ID: 19890253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics, lipid disorders, and treatment options.
    Gryn SE; Hegele RA
    Clin Pharmacol Ther; 2014 Jul; 96(1):36-47. PubMed ID: 24722394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population.
    Shu WY; Li JL; Wang XD; Huang M
    Acta Pharmacol Sin; 2015 May; 36(5):535-43. PubMed ID: 25891088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacogenomics of statins.
    Gelissen IC; McLachlan AJ
    Pharmacol Res; 2014 Oct; 88():99-106. PubMed ID: 24365577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics of statin responsiveness.
    Kajinami K; Akao H; Polisecki E; Schaefer EJ
    Am J Cardiol; 2005 Nov; 96(9A):65K-70K; discussion 34K-35K. PubMed ID: 16291017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic screening for polymorphisms within the UGT1A6 gene in three Chinese populations and function prediction through structural modeling.
    Xing Y; Yang L; Wang L; Shao L; Wei Z; Xuan J; Li J; Qin S; Shu A; He L; Xing Q
    Pharmacogenomics; 2009 May; 10(5):741-52. PubMed ID: 19450126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.